Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasms 28Breast Neoplasms 17Colorectal Neoplasms 14Prostatic Neoplasms 13Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 6Leukemia 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Pancreatic Neoplasms 4Lymphoma 4Endometrial Neoplasms 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Genetic Predisposition to Disease 3Disease 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Low Anterior Resection Syndrome 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Watchful Waiting 2Blood Specimen Collection 2Vital Signs 1Specimen Handling 1Rituximab 1Observation 1Interviews as Topic 1Flow Cytometry 1Filgrastim 1Data Collection 1COVID-19 Vaccines 1Bortezomib 1Blood Viscosity 1Albumins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hematologic Diseases × Interviews as Topic × Clear all
NCT00909207 2014-07-14

Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing

M.D. Anderson Cancer Center

Completed
20 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡